| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/08/1999 | WO1999010510A3 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain |
| 07/08/1999 | WO1999009057A3 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 07/08/1999 | WO1999004810A3 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 07/08/1999 | WO1999004265A9 Cancer associated nucleic acids and polypeptides |
| 07/08/1999 | WO1999002676A3 Mutants of gef proteins |
| 07/08/1999 | WO1998055594A3 Methods for chondrocyte growth and differentiation |
| 07/08/1999 | WO1998045711A3 Assay for ligands to tyrosine kinase receptors |
| 07/08/1999 | DE19757932A1 Oligopeptide Oligopeptides |
| 07/08/1999 | DE19749073C1 New protein, LUS-I, and related nucleic acid, antibodies, inhibitors and transgenic animals |
| 07/08/1999 | CA2317698A1 Composition and method for dermal and transdermal administration of a cytokine |
| 07/08/1999 | CA2316811A1 Anti-retroviral immunogens, preparation and use |
| 07/08/1999 | CA2316545A1 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
| 07/08/1999 | CA2316397A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 07/08/1999 | CA2316396A1 Tumor antigen protein, gene thereof, and utilization thereof |
| 07/08/1999 | CA2316385A1 Prodrugs of naaladase inhibitors |
| 07/08/1999 | CA2316283A1 Novel guanosine triphosphate (gtp) binding protein-coupled receptor protein |
| 07/08/1999 | CA2316282A1 Regulatory dna sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereof |
| 07/08/1999 | CA2316275A1 Carbohydrates, useful in solid delivery systems |
| 07/08/1999 | CA2316079A1 Human regulatory proteins |
| 07/08/1999 | CA2316017A1 Reagents and methods useful for detecting diseases of the breast |
| 07/08/1999 | CA2315977A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | CA2315750A1 A process for preparing human proinsulin |
| 07/08/1999 | CA2315702A1 V196 dna and polypeptides |
| 07/08/1999 | CA2315679A1 Vitamin e derivatives |
| 07/08/1999 | CA2315617A1 Human signal peptide-containing proteins |
| 07/08/1999 | CA2315297A1 Desaturase |
| 07/08/1999 | CA2315276A1 Human papillomavirus vaccine |
| 07/08/1999 | CA2313246A1 Polypeptide, their production and use |
| 07/08/1999 | CA2281938A1 Production process for intravenous immune serum globulin and resultant product |
| 07/07/1999 | EP0927763A2 Novel aroA |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927757A1 Methods and means for inducing apoptosis by interfering with Bip-like proteins |
| 07/07/1999 | EP0927755A2 Haloaccloacetate reductase, method for producing said enzyme, and method for producing alcohols using said enzyme |
| 07/07/1999 | EP0927723A1 Bicyclic depsipeptides promoting the production of apolipoprotein E |
| 07/07/1999 | EP0927716A1 Angiogenesis inhibitor |
| 07/07/1999 | EP0927557A1 Use of fructose diphosphate to reduce cyclosporine dosages after organ transplantation |
| 07/07/1999 | EP0927257A2 Human protein kinases |
| 07/07/1999 | EP0927254A1 Antagonists of interleukin-15 |
| 07/07/1999 | EP0927252A1 Antibodies against interferon alpha/beta receptor |
| 07/07/1999 | EP0927250A1 HUMAN POLYHOMEOTIC 1(hphl) ACTS AS A TUMOR SUPPRESSOR |
| 07/07/1999 | EP0927248A1 Secreted proteins and polynucleotides encoding them |
| 07/07/1999 | EP0927244A1 Semi-allogeneic cell hybrids as preventive and therapeutic vaccines for cancer and aids |
| 07/07/1999 | EP0927196A1 Polymers containing polysaccharides such as alginates or modified alginates |
| 07/07/1999 | EP0927195A2 Process for producing a plasma protein-containing medicament |
| 07/07/1999 | EP0927192A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/07/1999 | EP0927191A2 Anti-inflammatory peptides and uses thereof |
| 07/07/1999 | EP0927190A1 Central nervous system-derived immune privilege factor and uses thereof |
| 07/07/1999 | EP0927046A1 Mammalian regulator of nonsense-mediated rna decay |
| 07/07/1999 | EP0927045A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 07/07/1999 | EP0927042A1 Prevention of gastrointestinal damage |
| 07/07/1999 | EP0927038A1 P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent |
| 07/07/1999 | EP0927024A2 Device and method for treating ophthalmic diseases |
| 07/07/1999 | EP0927023A1 Composition for treating acne |
| 07/07/1999 | EP0926955A1 Conjugates useful in the treatment of prostate cancer |
| 07/07/1999 | EP0759029B1 Modified milk growth factor |
| 07/07/1999 | EP0661985B1 Peptides capable of binding cd8 molecules on ctl precursors |
| 07/07/1999 | EP0587799B1 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation |
| 07/07/1999 | EP0585412B1 Increasing blood-brain barrier permeability with permeabilizer peptides |
| 07/07/1999 | EP0537166B1 Water-soluble polypeptides having high affinity for interferons alpha and beta |
| 07/07/1999 | EP0527916B1 Antisense inhibitors of the human immunodeficiency virus |
| 07/07/1999 | EP0502188B1 Cloned glutamic acid decarboxylase |
| 07/07/1999 | CN1222194A T-cell selective interleukin-4 agonists |
| 07/07/1999 | CN1222193A Extracellular matrix signalling molecules |
| 07/07/1999 | CN1222162A Mutated nonactivating IgG2 domains and anti-cd3 antibodies incorporating same |
| 07/07/1999 | CN1222084A Insulin preparations containing carbohydrates |
| 07/07/1999 | CN1222083A Insulin Preparations containing NaCl |
| 07/07/1999 | CN1222082A Compsns. comprising antifungal agent and acetate buffer |
| 07/07/1999 | CN1222081A Method for prevention and treatment of mastitis |
| 07/07/1999 | CN1221752A Novel lantibiotic related to actagardine, and process for preparation and use thereof |
| 07/07/1999 | CN1221751A Extract of mammal eyes |
| 07/06/1999 | US5919926 Salinamides |
| 07/06/1999 | US5919912 Mammalian IAP antibodies and diagnostic kits |
| 07/06/1999 | US5919911 Monoclonal antibodies to stem cell factor receptors |
| 07/06/1999 | US5919910 Monoclonal antibodies |
| 07/06/1999 | US5919908 Protein formulation comprising coagulation factor VIII or factor IX in an aqueous solution |
| 07/06/1999 | US5919904 Response regulator polypeptides; screening for bactericides |
| 07/06/1999 | US5919903 Low affinity human IL-12 beta2 receptor |
| 07/06/1999 | US5919902 Increased stability in circulation; leptin binding proteins used for diagnosis and treatment of obesity |
| 07/06/1999 | US5919900 Modified hookworm neutrophil inhibitors |
| 07/06/1999 | US5919897 MU opioid receptor ligands: agonists and antagonists |
| 07/06/1999 | US5919896 PF4A receptor |
| 07/06/1999 | US5919773 Antisense oligonucleotide modulation of raf gene expression |
| 07/06/1999 | US5919771 Urea and thiourea derivatives of glycopeptides |
| 07/06/1999 | US5919769 Antiinflammatory agent |
| 07/06/1999 | US5919766 Storage stability by incorporating nonionic surfactant, sodium or potassium chloride, histidine |
| 07/06/1999 | US5919765 Inhibitors of factor XA |
| 07/06/1999 | US5919764 Detecting tumor having p185 on cell surfaces by administering peptide and detecting localized peptide in body of patient |
| 07/06/1999 | US5919763 IL-6/SIL-6R complex for promotion of liver functions |
| 07/06/1999 | US5919762 Conjugates of hirudin and lipophilic compounds |
| 07/06/1999 | US5919761 Peptides for heparin and low molecular weight heparin anticoagulation reversal |
| 07/06/1999 | US5919759 Organ transplant; wound healing agents |
| 07/06/1999 | US5919758 Modified polypeptides with altered biological activity |
| 07/06/1999 | US5919757 Granulocyte colony stimulating factor mixture containingbuffer and surfactant |
| 07/06/1999 | US5919756 Amides |
| 07/06/1999 | US5919754 Method of inhibiting fibrinogen binding to endothelial cells with fibrinogen gamma chain peptides |
| 07/06/1999 | US5919702 Collecting wharton's jelly from umbilical cords, culturing so that pre-chondrocytes proliferate, isolating pre-chondrocytes which give rise to chondrocytes which produce cartilage tissue for therapeutic use |
| 07/06/1999 | US5919699 Amino acid transporters and uses |
| 07/06/1999 | US5919692 Ubiquitous ATP-sensitive potassium-channel genes |
| 07/06/1999 | US5919690 Dna sequence encoding a polypeptide derived from a strain of aspergillus having alpha-galactosidase activity which is not inhibited by galactose; host cells transformed for efficient biosynthesis of the galactosidase |
| 07/06/1999 | US5919688 Enzyme with B-1, 3-glucanase activity |